Firming Eye Cream Base

1. INCI et CAS

INCI: Caffeine · CAS: 58-08-2

2. Rôle dans la formule

Caffeine is listed as a conditioning ingredient in this development reference. The recorded formula also lists Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. Review application feel and conditioning performance in the complete formula.

3. Niveaux d'emploi typiques (repère de formulation)

• The guide level assigned to this component is 0.3% w/w.

Dissolve in water.

4. Sources réglementaires et conformité mondiale

• The page provides development guidance; it does not authorize a particular grade or finished formula; The reference does not authorize a finished product.

5. Sécurité et évaluation des risques

Treat the listed amount as cosmetic-development guidance; it does not authorize a drug or OTC product with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Protect sealed bulk from warmth and direct light; where oxidation is a concern, evaluate airless or pump packaging; confirm compatibility and stability using the selected formula and pack.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Caffeine in a direction centered on caffeine eye-care.

• The available ingredient details does not demonstrate claims of drug activity, a clinical cure, or an undocumented product certification.
• The available details for Caffeine should not be used to substantiate whitening, acne-treatment, antiperspirant, sun-protection, or hair-growth benefits.

1. INCI et CAS

INCI: Palmitoyl Tripeptide-1 · CAS: 147732-56-7

2. Rôle dans la formule

Palmitoyl Tripeptide-1 is listed as a cosmetic peptide in this development reference. The recorded formula also lists Caffeine and Palmitoyl Tetrapeptide-7. Review the specified ingredient grade and evidence for the complete formula's intended claims.

3. Niveaux d'emploi typiques (repère de formulation)

• The guide level assigned to this component is 0.08% w/w.

Follow the supplier blend TDS. Many trade blends are already diluted.

4. Sources réglementaires et conformité mondiale

• This note is supplied for formulation development; it establishes no approval for the raw material or the final product; The finished cosmetic is outside the approval represented by this note.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; no drug approval or OTC status is conferred by this entry with patch and stability testing still needed for the completed formula.

6. Stabilité et conditionnement

Maintain cool, closed, light-protected storage for the bulk material; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; confirm final stability and pack compatibility on a representative batch.

7. Formulations d'allégations (à faire / à éviter)

• This guide frames Palmitoyl Tripeptide-1's cosmetic direction around peptide firming.

• The ingredient guidance does not demonstrate therapeutic results, cure claims, or unverified certification claims.
• The information about Palmitoyl Tripeptide-1 does not demonstrate whitening, treatment of acne, perspiration control, sun protection, or hair growth.

1. INCI et CAS

INCI: Palmitoyl Tetrapeptide-7 · CAS: en attente de confirmation du fournisseur ou de la réglementation pour le grade sélectionné

2. Rôle dans la formule

Palmitoyl Tetrapeptide-7 is listed as a cosmetic peptide in this development reference. The recorded formula also lists Caffeine and Palmitoyl Tripeptide-1. Review the specified ingredient grade and evidence for the complete formula's intended claims.

3. Niveaux d'emploi typiques (repère de formulation)

• The guide level assigned to this component is 0.05% w/w.

Follow the blend TDS.

4. Sources réglementaires et conformité mondiale

• This listing is guidance for formula development; it does not verify or approve the material grade or completed formula; No authorization for the final cosmetic is implied.

5. Sécurité et évaluation des risques

This formulation note gives a cosmetic-use reference level; it does not authorize a drug or OTC product so the finished cosmetic should receive patch and stability checks.

6. Stabilité et conditionnement

Keep the bulk container closed and shaded in a cool area; review airless or pump options if oxidation presents a concern; use batch testing to verify stability and package compatibility.

7. Formulations d'allégations (à faire / à éviter)

• For cosmetic use, this entry records Palmitoyl Tetrapeptide-7 in a direction centered on second peptide.

• The development record is not evidence of claims of drug activity, a clinical cure, or an undocumented product certification.
• The formulation record for Palmitoyl Tetrapeptide-7 should not be used to substantiate whitening, treatment of acne, perspiration control, sun protection, or hair growth.